Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Spine Deform ; 9(5): 1253-1258, 2021 09.
Article in English | MEDLINE | ID: mdl-33792837

ABSTRACT

The association between Chiari 1 malformation and scoliosis is well known in the literature. Prevalence has increased after the advent of magnetic resonance imaging. In children with this association, prophylactic suboccipital decompression prior to scoliosis correction is a common surgical procedure although the rationale for this surgical management and whether not performing it may lead to spinal cord injury has not been clearly elucidated. We conducted a systematic review of the literature with the aim to obtain strong data to support the hypothesis that it is safe to proceed with scoliosis correction without prior prophylactic suboccipital decompression for Chiari 1 in an asymptomatic population. Using the Prisma methodology, we analyzed 3250 studies published between 1972 and 2018. Only four studies met the inclusion criteria. None of the studies had a level of evidence high enough to recommend prophylactic decompression previous to correction of the spinal deformity.


Subject(s)
Arnold-Chiari Malformation , Scoliosis , Arnold-Chiari Malformation/diagnostic imaging , Arnold-Chiari Malformation/surgery , Child , Decompression, Surgical , Humans , Retrospective Studies , Scoliosis/diagnostic imaging , Scoliosis/surgery , Treatment Outcome
2.
Spine Deform ; 9(2): 615-620, 2021 03.
Article in English | MEDLINE | ID: mdl-33083998

ABSTRACT

STUDY DESIGN: Case report. OBJECTIVE: To report the clinical and imaging findings of a patient with the extremely rare association of aneurysmal bone cyst and osteoblastoma in the cervical spine. To our knowledge, only three cases have been reported in the published literature in children under 16 years of age with this condition in the cervical spine. METHODS: The patient's history, physical examination, imaging findings, and management with a complete 4-year medical history, surgical intervention and radiological follow-up are reported. RESULTS: A 4-year 11-month-old boy was diagnosed with aneurysmal bone cyst in association of osteoblastoma and was treated with CT-guided intralesional injection calcitonin and methylprednisolone. During the course of intralesional therapy, a pathological fracture of C2 was produced. Subsequently, a widened intralesional excision and instrumented fusion from occiput to cervical spine (C0-C4) was performed. CONCLUSION: The association of aneurysmal bone cyst and osteoblastoma in spine is extremely rare. Although both are benign lesions, in the cervical location, complete removal of the tumors is challenging. Wide resection with reconstruction of the segments for stability associated with adjuvant treatment with calcitonin and corticosteroids provides a good option.


Subject(s)
Bone Cysts, Aneurysmal , Bone Neoplasms , Osteoblastoma , Bone Cysts, Aneurysmal/diagnostic imaging , Bone Cysts, Aneurysmal/surgery , Bone Neoplasms/diagnostic imaging , Bone Neoplasms/surgery , Cervical Vertebrae/diagnostic imaging , Cervical Vertebrae/surgery , Child , Humans , Infant , Male , Osteoblastoma/diagnostic imaging , Osteoblastoma/surgery , Radiography
3.
Dig Liver Dis ; 33(1): 41-8, 2001.
Article in English | MEDLINE | ID: mdl-11303974

ABSTRACT

AIMS: To evaluate the prevalence, incidence and clinical relevance of bacterial infection in predominantly non-alcoholic cirrhotic patients hospitalised for decompensation. PATIENTS/METHODS: A total of 405 consecutive admissions in 361 patients (249 males and 112 females; 66 Child-Pugh class B and 295 class C) were analysed. Blood, urine, ascitic and pleural fluid cultures were performed within the first 24 hours, during hospitalisation whenever infection was suspected, and again before discharge. RESULTS: Over a one year period, 150 (34%) bacterial infections (89 community- and 61 hospital-acquired) involving urinary tract (41%), ascites (23%), blood (21%) and respiratory tract (17%) were diagnosed. The prevalence of bacterial peritonitis was 12%. Infections were asymptomatic in 69 cases (46%) and 130 (87%) involved a single site. Enteric flora accounted for 62% of infections, Escherichia Coli being the most frequent pathogen (25%). Community-acquired infections were associated with more advanced liver disease (Child-Pugh mean score 10.2+/-2.1 versus 9.5+/-1.9, p<0.05), renal failure (p<0.05), and high white blood cell count (p<0.01). Hospital-acquired infections occurred more frequently in patients admitted for gastrointestinal bleeding (p<0.05). The in-hospital mortality was significantly higher in infected than in non-infected patients (15% versus 7%, p<0.05), and infection emerged as an independent variable affecting survival. Moreover bacterial infection accounted for a significantly prolonged hospital stay. CONCLUSIONS: Bacterial infection, regardless of the aetiology, is a severe complication of decompensated cirrhosis, and, although frequently asymptomatic, accounts for both longer hospital stay and increased mortality.


Subject(s)
Bacterial Infections/mortality , Cross Infection/mortality , Liver Cirrhosis/mortality , Opportunistic Infections/mortality , Aged , Bacterial Infections/immunology , Cross Infection/immunology , Cross-Sectional Studies , Female , Hospital Mortality , Humans , Immune Tolerance/immunology , Incidence , Italy/epidemiology , Length of Stay/statistics & numerical data , Liver Cirrhosis/immunology , Male , Middle Aged , Opportunistic Infections/immunology , Prospective Studies , Risk Factors
4.
Ital J Gastroenterol Hepatol ; 29(3): 262-6, 1997 Jun.
Article in English | MEDLINE | ID: mdl-9646219

ABSTRACT

BACKGROUND: Selective intestinal decontamination has been proposed to prevent bacterial infection in cirrhosis. AIMS: To evaluate the efficacy of ciprofloxacin as selective intestinal decontaminant. PATIENTS AND METHODS: Quantitative microbiological studies on serial faeces were carried out in 15 cirrhotic patients. Ciprofloxacin was given orally at the starting dose of 250 mg every 12 hours for 7 days followed by a single dose of 250 mg/day from day 7 to day 14 and 125 mg/day for the next 3 weeks. Total stool samples were examined in basal conditions and on days 7, 14, 21, 28 and 35 of treatment and 3 and 7 days after treatment withdrawal. RESULTS: Gram-negative flora was completely eliminated in all patients by ciprofloxacin given at doses of 500 and 250 mg/day. When the drug was tapered to 125 mg/day, Escherichia coli reappeared in stools of 7 patients (antibiotic-resistant in one patient) and Klebsiella oxytoca in two patients (antibiotic-resistant in one patient). Faecal concentration of Group D Streptococcus was significantly increased at the end of therapy (basal mean 7.7 +/- 1.2 log CFU vs post treatment mean 9.6 +/- 0.5 log CFU, p < 0.05) while the faecal concentration of anaerobic flora and Candida albicans showed no change. CONCLUSIONS: Results of this study demonstrate the efficacy of oral ciprofloxacin as a selective intestinal decontaminant and ciprofloxacin 250 mg/day is the recommended dose for maintaining Selective Intestinal Decontamination. However, the risks of inducing antibiotic resistance in Gram-negative flora and promoting overgrowth of Gram-positive flora must be carefully considered in all patients chronically treated with oral quinolones.


Subject(s)
Anti-Infective Agents/therapeutic use , Antibiotic Prophylaxis , Ciprofloxacin/therapeutic use , Liver Cirrhosis/microbiology , Administration, Oral , Anti-Infective Agents/administration & dosage , Bacterial Infections/prevention & control , Ciprofloxacin/administration & dosage , Feces/microbiology , Female , Gram-Negative Bacteria/isolation & purification , Gram-Positive Bacteria/isolation & purification , Humans , Liver Cirrhosis/complications , Liver Cirrhosis/drug therapy , Male , Middle Aged , Statistics, Nonparametric
SELECTION OF CITATIONS
SEARCH DETAIL
...